These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 27748629

  • 1. TNF-alpha antagonist induced lupus on three different agents.
    Mudduluru BM, Shah S, Shamah S, Swaminath A.
    Postgrad Med; 2017 Mar; 129(2):304-306. PubMed ID: 27748629
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. TNF-inhibitor induced lupus in a patient treated with adalimumab for rheumatoid arthritis.
    Lieberman MR, Liebman TN, Alapati U, Khachemoune A.
    Dermatol Online J; 2014 Dec 13; 21(2):. PubMed ID: 25756476
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F, Portela F.
    BioDrugs; 2010 Dec 14; 24 Suppl 1():3-14. PubMed ID: 21175228
    [Abstract] [Full Text] [Related]

  • 8. Anti-TNF-induced lupus.
    Williams EL, Gadola S, Edwards CJ.
    Rheumatology (Oxford); 2009 Jul 14; 48(7):716-20. PubMed ID: 19416947
    [Abstract] [Full Text] [Related]

  • 9. Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept.
    Aghdashi MA, Khadir M, Dinparasti-Saleh R.
    Curr Rheumatol Rev; 2020 Jul 14; 16(1):61-66. PubMed ID: 31057111
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?
    Santiago T, Santiago MG, Rovisco J, Duarte C, Malcata A, da Silva JA.
    Clin Rheumatol; 2013 Dec 14; 32(12):1819-22. PubMed ID: 23955767
    [Abstract] [Full Text] [Related]

  • 12. TNF-α antagonists beyond approved indications: stories of success and prospects for the future.
    Karampetsou MP, Liossis SN, Sfikakis PP.
    QJM; 2010 Dec 14; 103(12):917-28. PubMed ID: 20802008
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A Rare Case of Drug-induced Erectile Dysfunction with Adalimumab and Certolizumab Solved after Switch to Ustekinumab in a Crohn's Disease Patient.
    Hidalgo-Rios S, Alonso-Moreno M, Iserte JT, Herrera-Justiniano JM.
    Curr Drug Saf; 2023 Dec 14; 18(3):374-378. PubMed ID: 35507800
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Certolizumab pegol: new drug. As a last resort in Crohn's disease: continue to use other TNF alpha inhibitors.
    Prescrire Int; 2009 Jun 14; 18(101):108-10. PubMed ID: 19637418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.